breast cancer cell line mda-mb-231 Search Results


93
ATCC human breast adenocarcinoma line mda mb 231
Cell Viability of gold anticancer agents, gold-loaded peptide nanofilaments ( PD+1 , PD+2 , AD+1 , AD+2 ), and peptides ( PD , AD ) in three human cell lines. Caki-1 <t>(renal</t> <t>cancer),</t> <t>MDA-MB-231</t> (Triple Negative Breast Cancer), and IMR-90 (lung fibroblasts) incubated with drug-loaded peptide for 72 h. A) Compound 1 , B) Compound 2 . (* represents P <0.05, ** represents P <0.01, *** represents P <0.001).
Human Breast Adenocarcinoma Line Mda Mb 231, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/breast+cancer+cell+line+mda-mb-231/High+molecular+weight+genomic+DNA+isolated+from+MDA-MB-231%3B+Breast+Adenocarcinoma%3B+Human+cell+line/pmc10720394-321-0-15
Average 93 stars, based on 1 article reviews
human breast adenocarcinoma line mda mb 231 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Genecopoeia mda mb 231 cell line
Cell Viability of gold anticancer agents, gold-loaded peptide nanofilaments ( PD+1 , PD+2 , AD+1 , AD+2 ), and peptides ( PD , AD ) in three human cell lines. Caki-1 <t>(renal</t> <t>cancer),</t> <t>MDA-MB-231</t> (Triple Negative Breast Cancer), and IMR-90 (lung fibroblasts) incubated with drug-loaded peptide for 72 h. A) Compound 1 , B) Compound 2 . (* represents P <0.05, ** represents P <0.01, *** represents P <0.001).
Mda Mb 231 Cell Line, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/breast+cancer+cell+line+mda-mb-231/MDA-MB-231+human+breast+adenocarcinoma+cancer+cell+line+dual-labeled+with+luciferase+and+GFP/pm38726005-45-2-8
Average 94 stars, based on 1 article reviews
mda mb 231 cell line - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
iCell Gene Therapeutics mda-mb-231 cells icell-h133
Cell Viability of gold anticancer agents, gold-loaded peptide nanofilaments ( PD+1 , PD+2 , AD+1 , AD+2 ), and peptides ( PD , AD ) in three human cell lines. Caki-1 <t>(renal</t> <t>cancer),</t> <t>MDA-MB-231</t> (Triple Negative Breast Cancer), and IMR-90 (lung fibroblasts) incubated with drug-loaded peptide for 72 h. A) Compound 1 , B) Compound 2 . (* represents P <0.05, ** represents P <0.01, *** represents P <0.001).
Mda Mb 231 Cells Icell H133, supplied by iCell Gene Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/breast+cancer+cell+line+mda-mb-231/breast+cancer+cell+lines++mcf+7++t47d++bt474++skbr3++mda+mb+453++mda+mb+231/pmc08536438-36-0-6
Average 90 stars, based on 1 article reviews
mda-mb-231 cells icell-h133 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Ricerche Srl mdamb231 breast cancer cell line
IL-1 β increases <t>MDAMB231</t> cell migratory ability under hypoxia. Data are shown as means ± SEM. ∗ P < 0.05, statistically significant difference between IL-1 β -treated hypoxic cells (IL-1 β ) and hypoxic control cells (Ctr). (a) The migration assay was performed as described in . The migration index was calculated as a fold change of relative CyQuant fluorescence of cells migrating into the lower chamber normalized to that of the untreated samples (Ctr) ( n = 4). Migrating cells were photographed and photomicrographs of representative fields from the indicated conditions were shown. (b) Protein expression of HIF-1 α was determined by Western blot analysis at indicated time points. β -actin was used as loading control. A representative blot from three independent experiments is shown. Quantification of HIF-1 α protein expression was achieved by chemiluminescence. (c) CXCR1 mRNA expression was determined by qRT-PCR analysis ( n = 3). (d) Protein expression of phospho-p38 was determined by Western blot analysis. (e) VEGF-A mRNA and protein expression were analyzed by qRT-PCR and ELISA ( n = 3). (f) Protein and mRNA expression of NF κ B was determined by Western blot and qRT-PCR analysis ( n = 3). (g) CXCL8 mRNA and protein expression were analyzed by qRT-PCR and ELISA ( n = 3).
Mdamb231 Breast Cancer Cell Line, supplied by Ricerche Srl, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/breast+cancer+cell+line+mda-mb-231/mdamb231+breast+cancer+cell+line/pmc04677223-31-0-16
Average 90 stars, based on 1 article reviews
mdamb231 breast cancer cell line - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
COLD SPRING BIOTECH CORP mda-mb-231 cell line
IL-1 β increases <t>MDAMB231</t> cell migratory ability under hypoxia. Data are shown as means ± SEM. ∗ P < 0.05, statistically significant difference between IL-1 β -treated hypoxic cells (IL-1 β ) and hypoxic control cells (Ctr). (a) The migration assay was performed as described in . The migration index was calculated as a fold change of relative CyQuant fluorescence of cells migrating into the lower chamber normalized to that of the untreated samples (Ctr) ( n = 4). Migrating cells were photographed and photomicrographs of representative fields from the indicated conditions were shown. (b) Protein expression of HIF-1 α was determined by Western blot analysis at indicated time points. β -actin was used as loading control. A representative blot from three independent experiments is shown. Quantification of HIF-1 α protein expression was achieved by chemiluminescence. (c) CXCR1 mRNA expression was determined by qRT-PCR analysis ( n = 3). (d) Protein expression of phospho-p38 was determined by Western blot analysis. (e) VEGF-A mRNA and protein expression were analyzed by qRT-PCR and ELISA ( n = 3). (f) Protein and mRNA expression of NF κ B was determined by Western blot and qRT-PCR analysis ( n = 3). (g) CXCL8 mRNA and protein expression were analyzed by qRT-PCR and ELISA ( n = 3).
Mda Mb 231 Cell Line, supplied by COLD SPRING BIOTECH CORP, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/breast+cancer+cell+line+mda-mb-231/mda+mb+231+human+breast+cancer+cell+line/pmc05707452__SC___006___C4SC03894K___s001-6-0-7
Average 90 stars, based on 1 article reviews
mda-mb-231 cell line - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
3-D Matrix mda-mb-231 breast cancer cells
Applied HA hydrogels scaffolding technologies in Cancer disease.
Mda Mb 231 Breast Cancer Cells, supplied by 3-D Matrix, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/breast+cancer+cell+line+mda-mb-231/breast+cancer++mcf7+and+mda+mb+231++cell+lines/pmc09568881-29-10-4
Average 90 stars, based on 1 article reviews
mda-mb-231 breast cancer cells - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
SYNLAB International GmbH human breast cancer cell line mda-mb-231
Applied HA hydrogels scaffolding technologies in Cancer disease.
Human Breast Cancer Cell Line Mda Mb 231, supplied by SYNLAB International GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/breast+cancer+cell+line+mda-mb-231/human+breast+cancer+cell+line+mda+mb+231/pmc10051563-68-7-28
Average 90 stars, based on 1 article reviews
human breast cancer cell line mda-mb-231 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Ubigene Biosciences Co Ltd breast cancer cell lines mda-mb-231
Applied HA hydrogels scaffolding technologies in Cancer disease.
Breast Cancer Cell Lines Mda Mb 231, supplied by Ubigene Biosciences Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/breast+cancer+cell+line+mda-mb-231/breast+cancer+cell+line+mda+mb+231/pmc11985923-30-9-16
Average 90 stars, based on 1 article reviews
breast cancer cell lines mda-mb-231 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Cells Online LLC gfp expressing mda-mb-231 breast adenocarcinoma cell line
Applied HA hydrogels scaffolding technologies in Cancer disease.
Gfp Expressing Mda Mb 231 Breast Adenocarcinoma Cell Line, supplied by Cells Online LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/breast+cancer+cell+line+mda-mb-231/gfp+expressing+mda+mb+231+breast+adenocarcinoma+cell+line/pm37455418-130-0-10
Average 90 stars, based on 1 article reviews
gfp expressing mda-mb-231 breast adenocarcinoma cell line - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
EPO GmbH breast cancer cell line mda-mb-231
Applied HA hydrogels scaffolding technologies in Cancer disease.
Breast Cancer Cell Line Mda Mb 231, supplied by EPO GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/breast+cancer+cell+line+mda-mb-231/breast+cancer+cell+line+mda+mb+231/pm36770730-473-8-16
Average 90 stars, based on 1 article reviews
breast cancer cell line mda-mb-231 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Cato Research cisplatin-resistant (mda/r) variants of the mda-mb-231 human breast cancer cell line
Applied HA hydrogels scaffolding technologies in Cancer disease.
Cisplatin Resistant (Mda/R) Variants Of The Mda Mb 231 Human Breast Cancer Cell Line, supplied by Cato Research, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/breast+cancer+cell+line+mda-mb-231/cisplatin+resistant++mda+r++variants+of+the+mda+mb+231+human+breast+cancer+cell+line/10__1590_slash_s0100___40422003000300010-34-19-4
Average 90 stars, based on 1 article reviews
cisplatin-resistant (mda/r) variants of the mda-mb-231 human breast cancer cell line - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
SAURER Inc breast carcinoma cell line mda-mb 231
Applied HA hydrogels scaffolding technologies in Cancer disease.
Breast Carcinoma Cell Line Mda Mb 231, supplied by SAURER Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/breast+cancer+cell+line+mda-mb-231/breast+carcinoma+cell+line+mda+mb+231/pm21566961-62-31-6
Average 90 stars, based on 1 article reviews
breast carcinoma cell line mda-mb 231 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Cell Viability of gold anticancer agents, gold-loaded peptide nanofilaments ( PD+1 , PD+2 , AD+1 , AD+2 ), and peptides ( PD , AD ) in three human cell lines. Caki-1 (renal cancer), MDA-MB-231 (Triple Negative Breast Cancer), and IMR-90 (lung fibroblasts) incubated with drug-loaded peptide for 72 h. A) Compound 1 , B) Compound 2 . (* represents P <0.05, ** represents P <0.01, *** represents P <0.001).

Journal: Journal of the American Chemical Society

Article Title: Encapsulation of Gold-Based Anticancer Agents in Protease-Degradable Peptide Nanofilaments Enhances Their Potency

doi: 10.1021/jacs.2c09820

Figure Lengend Snippet: Cell Viability of gold anticancer agents, gold-loaded peptide nanofilaments ( PD+1 , PD+2 , AD+1 , AD+2 ), and peptides ( PD , AD ) in three human cell lines. Caki-1 (renal cancer), MDA-MB-231 (Triple Negative Breast Cancer), and IMR-90 (lung fibroblasts) incubated with drug-loaded peptide for 72 h. A) Compound 1 , B) Compound 2 . (* represents P <0.05, ** represents P <0.01, *** represents P <0.001).

Article Snippet: Human breast adenocarcinoma line MDA-MB-231 and human lung fibroblast line IMR-90 were obtained from the American Type Culture Collection (ATCC; Manassas, Virginia, USA) and cultured with Dulbecco’s modified Eagle’s medium (DMEM; Fisher Scientific) containing 10 % fetal bovine serum, certified, heat inactivated, US origin (FBS; Fisher Scientific), 1 % minimum essential media (MEM) nonessential amino acids (NEAA; Fisher Scientific), and 1 % penicillin–streptomycin (PenStrep; Fisher Scientific).

Techniques: Incubation

IL-1 β increases MDAMB231 cell migratory ability under hypoxia. Data are shown as means ± SEM. ∗ P < 0.05, statistically significant difference between IL-1 β -treated hypoxic cells (IL-1 β ) and hypoxic control cells (Ctr). (a) The migration assay was performed as described in . The migration index was calculated as a fold change of relative CyQuant fluorescence of cells migrating into the lower chamber normalized to that of the untreated samples (Ctr) ( n = 4). Migrating cells were photographed and photomicrographs of representative fields from the indicated conditions were shown. (b) Protein expression of HIF-1 α was determined by Western blot analysis at indicated time points. β -actin was used as loading control. A representative blot from three independent experiments is shown. Quantification of HIF-1 α protein expression was achieved by chemiluminescence. (c) CXCR1 mRNA expression was determined by qRT-PCR analysis ( n = 3). (d) Protein expression of phospho-p38 was determined by Western blot analysis. (e) VEGF-A mRNA and protein expression were analyzed by qRT-PCR and ELISA ( n = 3). (f) Protein and mRNA expression of NF κ B was determined by Western blot and qRT-PCR analysis ( n = 3). (g) CXCL8 mRNA and protein expression were analyzed by qRT-PCR and ELISA ( n = 3).

Journal: Mediators of Inflammation

Article Title: Interleukin-1 β Affects MDAMB231 Breast Cancer Cell Migration under Hypoxia: Role of HIF-1 α and NF κ B Transcription Factors

doi: 10.1155/2015/789414

Figure Lengend Snippet: IL-1 β increases MDAMB231 cell migratory ability under hypoxia. Data are shown as means ± SEM. ∗ P < 0.05, statistically significant difference between IL-1 β -treated hypoxic cells (IL-1 β ) and hypoxic control cells (Ctr). (a) The migration assay was performed as described in . The migration index was calculated as a fold change of relative CyQuant fluorescence of cells migrating into the lower chamber normalized to that of the untreated samples (Ctr) ( n = 4). Migrating cells were photographed and photomicrographs of representative fields from the indicated conditions were shown. (b) Protein expression of HIF-1 α was determined by Western blot analysis at indicated time points. β -actin was used as loading control. A representative blot from three independent experiments is shown. Quantification of HIF-1 α protein expression was achieved by chemiluminescence. (c) CXCR1 mRNA expression was determined by qRT-PCR analysis ( n = 3). (d) Protein expression of phospho-p38 was determined by Western blot analysis. (e) VEGF-A mRNA and protein expression were analyzed by qRT-PCR and ELISA ( n = 3). (f) Protein and mRNA expression of NF κ B was determined by Western blot and qRT-PCR analysis ( n = 3). (g) CXCL8 mRNA and protein expression were analyzed by qRT-PCR and ELISA ( n = 3).

Article Snippet: MDAMB231 breast cancer cell line and Topotecan were kindly provided by Dr. Raffaella Giavazzi (IRCCS-Istituto di Ricerche Farmacologiche Mario Negri Milano, Italy).

Techniques: Control, Migration, CyQUANT Assay, Fluorescence, Expressing, Western Blot, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay

Applied HA hydrogels scaffolding technologies in Cancer disease.

Journal: Materials Today Bio

Article Title: HYDRHA: Hydrogels of hyaluronic acid. New biomedical approaches in cancer, neurodegenerative diseases, and tissue engineering

doi: 10.1016/j.mtbio.2022.100453

Figure Lengend Snippet: Applied HA hydrogels scaffolding technologies in Cancer disease.

Article Snippet: HA-methacrylate-RGD , 2D , 3D Matrix stiffness Drug resistance , MDA-MB-231 breast cancer cells , Swelling Elastic Modulus Mesh Size , Cell proliferation Cell Morphological Analyses , [ , ] .

Techniques: Scaffolding, Inhibition, Migration, Time-lapse Microscopy, Expressing, Derivative Assay, Apoptosis Assay